Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines

by Yulia Desheva, Tatiana Smolonogina, Svetlana Donina, Larisa Rudenko
Published 2020-05-01

Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine.

by Victoria Matyushenko, Irina Isakova-Sivak, Tatiana Smolonogina, Irina Dubrovina, Tatiana Tretiak, Larisa Rudenko
Published 2017-01-01

Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.

by Yulia Desheva, Ivan Sychev, Tatiana Smolonogina, Andrey Rekstin, Natalia Ilyushina, Vladimir Lugovtsev, Anastasia Samsonova, Aleksey Go, Anna Lerner
Published 2018-01-01

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein

by Andrey Rekstin, Irina Isakova-Sivak, Galina Petukhova, Daniil Korenkov, Igor Losev, Tatiana Smolonogina, Tatiana Tretiak, Svetlana Donina, Svetlana Shcherbik, Tatiana Bousse, Larisa Rudenko
Published 2017-01-01

Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.

by Irina Isakova-Sivak, Jørgen de Jonge, Tatiana Smolonogina, Andrey Rekstin, Geert van Amerongen, Harry van Dijken, Justin Mouthaan, Paul Roholl, Victoria Kuznetsova, Elena Doroshenko, Vadim Tsvetnitsky, Larisa Rudenko
Published 2014-01-01